Epigenetic Regulation of Endothelial-Mesenchymal Transition in Vascular Atherosclerosis Development.
作者信息
Jang JaeHyuk, Park Hun-Jun
机构信息
Division of Cardiology, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Uijeongbu, Korea.
出版信息
Korean Circ J. 2025 May;55(5):456-458. doi: 10.4070/kcj.2025.0006. Epub 2025 Apr 7.
Abstract
摘要
相似文献
1
Epigenetic Regulation of Endothelial-Mesenchymal Transition in Vascular Atherosclerosis Development.
Korean Circ J. 2025 May;55(5):456-458. doi: 10.4070/kcj.2025.0006. Epub 2025 Apr 7.
2
Endothelial to mesenchymal transition in atherosclerotic vascular remodeling.
Clin Chim Acta. 2019 Mar;490:34-38. doi: 10.1016/j.cca.2018.12.018. Epub 2018 Dec 17.
3
Atherosclerotic Plaque Epigenetic Age Acceleration Predicts a Poor Prognosis and Is Associated With Endothelial-to-Mesenchymal Transition in Humans.
Arterioscler Thromb Vasc Biol. 2024 Jun;44(6):1419-1431. doi: 10.1161/ATVBAHA.123.320692. Epub 2024 Apr 18.
4
Endothelial-mesenchymal transition in atherosclerosis.
Cardiovasc Res. 2018 Mar 15;114(4):565-577. doi: 10.1093/cvr/cvx253.
5
Atheroprone flow enhances the endothelial-to-mesenchymal transition.
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1293-H1303. doi: 10.1152/ajpheart.00213.2018. Epub 2018 Jul 27.
6
Endothelial-to-Mesenchymal Transition Contributes to Accelerated Atherosclerosis in Hutchinson-Gilford Progeria Syndrome.
Circulation. 2024 Nov 12;150(20):1612-1630. doi: 10.1161/CIRCULATIONAHA.123.065768. Epub 2024 Aug 29.
7
Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis.
Vascul Pharmacol. 2024 Jun;155:107368. doi: 10.1016/j.vph.2024.107368. Epub 2024 Mar 26.
8
Endothelial-to-mesenchymal transition: New insights into vascular calcification.
Biochem Pharmacol. 2023 Jul;213:115579. doi: 10.1016/j.bcp.2023.115579. Epub 2023 Apr 30.
9
Endothelial Reprogramming in Atherosclerosis.
Bioengineering (Basel). 2024 Mar 27;11(4):325. doi: 10.3390/bioengineering11040325.
10
Isoforskolin, adenylate cyclase agonist, inhibits endothelial-to-mesenchymal transition in atherosclerosis.
Phytomedicine. 2025 Apr;139:156520. doi: 10.1016/j.phymed.2025.156520. Epub 2025 Feb 16.
本文引用的文献
1
LncRNA uc003pxg.1 Interacts With miR-339-5p Promote Vascular Endothelial Cell Proliferation, Migration and Angiogenesis.
Korean Circ J. 2025 May;55(5):440-455. doi: 10.4070/kcj.2024.0153. Epub 2024 Nov 18.
2
Endothelial to Mesenchymal Transition: An Insight in Atherosclerosis.
Front Cardiovasc Med. 2021 Sep 17;8:734550. doi: 10.3389/fcvm.2021.734550. eCollection 2021.
3
Non-coding RNA in endothelial-to-mesenchymal transition.
Cardiovasc Res. 2019 Oct 1;115(12):1716-1731. doi: 10.1093/cvr/cvz211.
4
NEAT1 induces osteosarcoma development by modulating the miR-339-5p/TGF-β1 pathway.
J Cell Physiol. 2019 Apr;234(4):5097-5105. doi: 10.1002/jcp.27313. Epub 2018 Sep 10.
5
Endothelial-mesenchymal transition in atherosclerosis.
Cardiovasc Res. 2018 Mar 15;114(4):565-577. doi: 10.1093/cvr/cvx253.
6
TGF-β Signaling from Receptors to Smads.
Cold Spring Harb Perspect Biol. 2016 Sep 1;8(9):a022061. doi: 10.1101/cshperspect.a022061.
7
Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability.
Nat Commun. 2016 Jun 24;7:11853. doi: 10.1038/ncomms11853.
8
Endothelial-to-mesenchymal transition drives atherosclerosis progression.
J Clin Invest. 2015 Oct 26;125(12):4514-28. doi: 10.1172/JCI82719.
9
Endothelial function and dysfunction: testing and clinical relevance.
Circulation. 2007 Mar 13;115(10):1285-95. doi: 10.1161/CIRCULATIONAHA.106.652859.
10
Role of endothelial dysfunction in atherosclerosis.
Circulation. 2004 Jun 15;109(23 Suppl 1):III27-32. doi: 10.1161/01.CIR.0000131515.03336.f8.
Zotero 插件